Judicial Watch’s action shines light on the FDA’s lack of transparency regarding the dangerous drug mifepristone, after 22 years, and progressively diminished supervision, the American public still has no reassurance regarding the quality of the manufacturing process or the quantity of complications because the FDA does not mandate complication reporting unless it results in a woman’s death.
This page is about the voters of this citizen quote.
We're doing our best to make sure our content is useful, accurate and safe. If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Share your thoughts on this citizen quote voters with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In